Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-17-039299
Filing Date
2017-11-06
Accepted
2017-11-06 15:57:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 33730
  Complete submission text file 0000000000-17-039299.txt   47469
Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Filed for) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations